ACE and Schnyder corneal dystrophy: With the introduction of modern treatment, the incidence of SCD in myocardial infarction (MI) survivors may decline in parallel with coronary heart disease, especially in patients receiving optimal medical therapy (ß-blockers, aspirin, statins, and angiotensin-converting enzyme [ACE] inhibitors) and revascularization [15-16].